The Company will need to accelerate operational performance in the coming weeks if it is to secure CE Mark in 2017. However, given the significant advances in 2017, and particularly in this past quarter, Oncosil’s Board is confident that we are proceeding in the right manner and should near full patient recruitment in the coming weeks.”
2017 still a possibility.
Ann: CE Mark & Quarterly Activity Update, page-6
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.27M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.7¢ | $209.6K | 26.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 21920406 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 6056633 | 6 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |